Why BGPT?
logo

The Evidence Layer for Scientific AI

Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.

Press Enter ↡ to search evidence



    Explore by Goal












     Quick Explanation


    I can’t run a meta-analysis for β€œMCM2 breast cancer hazard ratios across cohorts” from the data provided.
    I only see hazard ratios/study details for other exposures/biomarkers (e.g., PRS for BRCA carriers, night work, tumour morphology, TNF inhibitors, dietary patterns, interferon metagene, stress, physical activity/disability, etc.). None of the provided research entries contain MCM2-specific hazard ratios or cohort-level MCM2 effect estimates, so there’s no raw HR data to pool and no study-level risk-of-bias inputs for MCM2.
    If you share the MCM2 cohort effect sizes (HR, 95% CI or SE, and which model/timepoint) or provide the MCM2 papers/rows, I can compute pooled HRs + heterogeneity + risk-of-bias summaries.



     Long Explanation


    Meta-analysis request: β€œMCM2 breast cancer hazard ratios across cohorts (risk of bias)”
    Blocking issue: The β€œRESEARCH DATA TO UTILIZE + GRAPH” you provided does not include any MCM2-specific hazard ratios (or cohort-level effect estimates) for breast cancer.
    Therefore, I cannot truthfully pool hazard ratios, estimate heterogeneity, or score risk of bias β€œfor MCM2” from the supplied rowsβ€”there are no MCM2 effect sizes or MCM2-related bias inputs to compute.
    What I would need to proceed (any one works):
    • MCM2 cohort rows with effect sizes: HR (and 95% CI or SE), plus which outcome (DFS/OS/recurrence) and time horizon.
    • The MCM2 papers/rows themselves so I can extract HRs directly from full text.
    • A CSV/table you upload with columns like: study, cohort, HR, lowerCI, upperCI, outcome, censoring/model.
    Data audit (what’s present vs what’s missing)
    Next step inside BGPT
    Use BGPT to fetch MCM2 breast-cancer cohorts and extract HRs from full text, then I’ll run the pooling and risk-of-bias synthesis.
    This agent will iteratively search for the missing MCM2 cohort hazard ratios (from BGPT’s raw paper data) and then compute the meta-analysis + risk-of-bias synthesis.


    Feedback:    

    Updated: May 01, 2026

     Top Data Sources ExportMCP


     Hypothesis Graveyard


    A single global, subtype-independent effect of MCM2 on breast-cancer hazard is already established and small enough that it should appear consistently across all cohortsβ€”unlikely to hold if biology is subtype-dependent (to be tested once MCM2 HRs are extracted).

     Science Art


    Meta-analysis: MCM2 breast cancer hazard ratios across cohorts risk of bias Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending